A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

<div>Mutation characteristics of YY1 in various TCGA cancers. The features of YY1 mutations in TCGA cancers were examined using the cBioPortal. The frequency of alteration with mutation type (a) and site (b) is shown. The 3D structure of YY1 is displayed (c). We also utilized the cBioPortal to explore the possible association between mutation status and OS, DSS, DFS, and PFS of LUSC (d).</div>

Journal of Immunology Research

fig5

Figure 5

Figure 5: A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets 

Figure 5 | A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets 